These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15915006)

  • 21. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation.
    Rogueda PG; Price R; Smith T; Young PM; Traini D
    J Colloid Interface Sci; 2011 Sep; 361(2):649-55. PubMed ID: 21714970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ; Senn S; Mezzanotte WS
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the development of Respimat Soft Mist Inhaler.
    Dalby R; Spallek M; Voshaar T
    Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model for predicting size distributions delivered from pMDIs with suspended drug.
    Stein SW; Sheth P; Myrdal PB
    Int J Pharm; 2012 Jan; 422(1-2):101-15. PubMed ID: 22044537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The technical transition to CFC-free inhalers.
    Tansey I
    Br J Clin Pract Suppl; 1997 May; 89():22-7. PubMed ID: 9519509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen.
    Buttini F; Glieca S; Sonvico F; Lewis DA
    Expert Opin Drug Deliv; 2023; 20(8):1131-1143. PubMed ID: 37767756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the superiority of BDP/FF HFA pMDI fixed combination over the free combination of BDP CFC pMDI and FF DPI.
    García Arieta A
    Respir Med; 2009 Dec; 103(12):1969-70; author reply 1971-2. PubMed ID: 19744845
    [No Abstract]   [Full Text] [Related]  

  • 29. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
    Molimard M; Till D; Stenglein S; Singh D; Krummen M
    Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Principles of metered-dose inhaler design.
    Newman SP
    Respir Care; 2005 Sep; 50(9):1177-90. PubMed ID: 16122401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the molecular interactions in a pMDI formulation by atomic force microscopy.
    Ashayer R; Luckham PF; Manimaaran S; Rogueda P
    Eur J Pharm Sci; 2004 Mar; 21(4):533-43. PubMed ID: 14998585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of physical and chemical stability in pressurised metered dose inhalers: potential new techniques.
    Ooi J; Traini D; Boyd BJ; Gaisford S; Young PM
    Expert Opin Drug Deliv; 2015; 12(10):1661-75. PubMed ID: 26067386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
    Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of two methods to determine the solubility of compounds in aerosol propellants.
    Gupta A; Myrdal PB
    Int J Pharm; 2005 Mar; 292(1-2):201-9. PubMed ID: 15725567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
    Pu Y; Kline LC; Berry J
    Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the suspension stability of pharmaceuticals using a shadowgraphic imaging method.
    Wang H; Tan P; Barona D; Li G; Hoe S; Lechuga-Ballesteros D; Nobes DS; Vehring R
    Int J Pharm; 2018 Sep; 548(1):128-138. PubMed ID: 29959088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.